APAC Non-Hodgkin Lymphoma Market to Grow at 6.6% CAGR Through 2020,...

New research report “Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting” elaborated by GBI Research is now...(PRWeb September 26, 2014)Read the full story at http://www.prweb.com/releases/2014/09/prweb12203364.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news